The Macrophage: A Disputed Fortress in the Battle against Mycobacterium tuberculosis
Open accessAbstract
Mycobacterium tuberculosis (Mtb), the etiological agent of human tuberculosis (TB), has plagued humans for thousands of years. TB still remains a major public health problem in our era, causing more than 4,400 deaths worldwide every day and killing more people than HIV. After inhaling Mtb-contaminated aerosols, TB primo-infection starts in the terminal lung airways, where Mtb is taken up by alveolar macrophages. Although macrophages are known as professional killers for pathogens, Mtb has adopted remarkable strategies to circumvent host defenses, building suitable conditions to survive and proliferate. Within macrophages, Mtb initially resides inside phagosomes, where its survival mostly depends on its ability to take control of phagosomal processing, through inhibition of phagolysosome biogenesis and acidification processes, and by progressively getting access to the cytosol. Bacterial access to the cytosolic space is determinant for specific immune responses and cell death programs, both required for the replication and the dissemination of Mtb. Comprehension of the molecular events governing Mtb survival within macrophages is fundamental for the improvement of vaccine-based and therapeutic strategies in order to help the host to better defend itself in the battle against the fierce invader Mtb. In this mini-review, we discuss recent research exploring how Mtb conquers and transforms the macrophage into a strategic base for its survival and dissemination as well as the associated defense strategies mounted by host.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A number of secreted effectors, including EsxA (ESAT-6), EsxB (CFP-10), EspA, EspC, and PE/PPE proteins, have been suggested to intervene in host cellular and immune signaling pathways.
“Indeed, a number of secreted effectors, including EsxA (ESAT-6), EsxB (CFP-10), and ESX-1 secretion-associated proteins (Esp), such as EspA or EspC, as well as proteins that carry the characteristic N-terminal motifs Pro-Glu (PE) and Pro-Pro-Glu (PPE), have been suggested to intervene in host cellular and immune signaling pathways (11,24,25).”
From ESX/Type VII Secretion Systems—An Important Way Out for Mycobacterial Proteins (2019) · cites this paper as [25]
Mtb uses phagosomes of macrophages as a proliferative niche and inhibits fusion with lysosomes and avoids xenophagy.
“Like S.a., Mycobacterium tuberculosis (Mtb) uses phagosomes of macrophages as proliferative niche. Mechanisms to survive in phagosomes are the inhibition of fusion with lysosomes and avoiding to be targeted by xenophagy [255].”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [255]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847 · see citing works
Self-citationToll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response
Liu, P. T., Stenger, S., Li, H., Wenzel, L., Tan, B. H., Krutzik, S. R., Ochoa, M. T., Schauber, J., Wu, K., Meinken, C., et al. (2006) · Science · doi:10.1126/science.1123933 · Cited by 3,924 · see citing works
A Diarylquinoline Drug Active on the ATP Synthase of <i>Mycobacterium tuberculosis</i>
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science · doi:10.1126/science.1106753 · Cited by 2,191 · cited 1× · see citing works
“Concerning drug treatment of TB, most of the drugs used today date from the 1950s to 1960s, with a few exceptions, such as bedaquiline, a recently discovered ATP synthase inhibitor (Andries et al., 2005) that is currently used successfully in drug regimens against MDR-TB (Diacon et al.”
BackgroundBrennan, P. J., & Nikaido, H. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.000333 · Cited by 1,953 · see citing works
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
Barry, C. E., Boshoff, H. I., Dartois, V. A., Dick, T., Ehrt, S., Flynn, J. L., Schnappinger, D., Wilkinson, R. J., & Young, D. B. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2236 · Cited by 1,424 · see citing works
The Immune Response in Tuberculosis
O’Garra, A., Redford, P. S., McNab, F. W., Bloom, C. I., Wilkinson, R. J., & Berry, M. P. R. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095939 · Cited by 1,351 · see citing works
Sturgill-Koszycki, S., Schlesinger, P. H., Chakraborty, P., Haddix, P. L., Collins, H. L., Fok, A. K., Allen, R. D., Gluck, S. L., Heuser, J., & Russell, D. G. (1994) · Science · doi:10.1126/science.8303277 · Cited by 1,302 · see citing works
Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion
Thurston, T. L. M., Wandel, M. P., von Muhlinen, N., Foeglein, Á., & Randow, F. (2012) · Nature · doi:10.1038/nature10744 · Cited by 1,034 · see citing works
Armstrong, J. A., & Hart, P. D. (1971) · The Journal of Experimental Medicine · doi:10.1084/jem.134.3.713 · Cited by 991 · see citing works
M. tuberculosis and M. leprae Translocate from the Phagolysosome to the Cytosol in Myeloid Cells
van der Wel, N., Hava, D., Houben, D., Fluitsma, D., van Zon, M., Pierson, J., Brenner, M., & Peters, P. J. (2007) · Cell · doi:10.1016/j.cell.2007.05.059 · Cited by 960 · see citing works
The Role of the Granuloma in Expansion and Dissemination of Early Tuberculous Infection
Davis, J. M., & Ramakrishnan, L. (2009) · Cell · doi:10.1016/j.cell.2008.11.014 · Cited by 907 · see citing works
The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
Diacon, A. H., Pym, A. S., Grobusch, M. P., Patientia, R. F., Rustomjee, R., Page‐Shipp, L., Pistorius, C., Krause, R., Bogoshi, M., Churchyard, G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808427 · Cited by 836 · see citing works
Foamy macrophages and the progression of the human tuberculosis granuloma
Russell, D. G., Cardona, P.-J., Kim, M., Allain‐Maillet, S., & Altare, F. (2009) · Nature Immunology · doi:10.1038/ni.1781 · Cited by 822 · see citing works
Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle
Ishikawa, E., Ishikawa, T., Morita, Y. S., Toyonaga, K., Yamada, H., Takeuchi, O., Kinoshita, T., Akira, S., Yoshikai, Y., & Yamasaki, S. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20091750 · Cited by 794 · see citing works
Vitamin D3 Induces Autophagy in Human Monocytes/Macrophages via Cathelicidin
Yuk, J., Shin, D., Lee, H., Yang, C., Jin, H. S., Kim, K., Lee, Z., Lee, S.-H., Kim, J., & Jo, E. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.08.004 · Cited by 787 · see citing works
Type VII secretion — mycobacteria show the way
Abdallah, A. M., Gey van Pittius, N. C., DiGiuseppe Champion, P. A., Cox, J., Luirink, J., Vandenbroucke-Grauls, C. M. J. E., Appelmelk, B. J., & Bitter, W. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1773 · Cited by 763 · see citing works
Watson, R. O., Manzanillo, P. S., & Cox, J. S. (2012) · Cell · doi:10.1016/j.cell.2012.06.040 · Cited by 755 · see citing works
Pym, A. S., Brodin, P., Brosch, R., Huerre, M., & Cole, S. T. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03237.x · Cited by 729 · see citing works
Self-citationClemens, D. L., & Horwitz, M. A. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.1.257 · Cited by 681 · see citing works
Phagosome maturation: aging gracefully
Vieira, O. V., Botelho, R. J., & Grinstein, S. (2002) · Biochemical Journal · doi:10.1042/bj20020691 · Cited by 675 · see citing works
Watson, R. O., Bell, S. L., MacDuff, D. A., Kimmey, J. M., Diner, E. J., Olivas, J., Vance, R. E., Stallings, C. L., Virgin, H. W., & Cox, J. S. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.05.004 · Cited by 645 · see citing works
Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis
Pym, A. S., Brodin, P., Majlessi, L., Brosch, R., Demangel, C., Williams, A., Griffiths, K. E., Marchal, G., Leclerc, C., & Cole, S. T. (2003) · Nature Medicine · doi:10.1038/nm859 · Cited by 644 · see citing works
Self-citationDiscovery of Q203, a potent clinical candidate for the treatment of tuberculosis
Pethe, K., Bifani, P. J., Jang, J., Kang, S., Park, S., Ahn, S., Jiřiček, J., Jung, J., Jeon, H. K., Cechetto, J. D., et al. (2013) · Nature Medicine · doi:10.1038/nm.3262 · Cited by 601 · see citing works
Bafica, A., Scanga, C. A., Feng, C. G., Leifer, C., Cheever, A., & Sher, A. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051782 · Cited by 601 · see citing works
The ubiquitin ligase parkin mediates resistance to intracellular pathogens
Manzanillo, P. S., Ayres, J. S., Watson, R. O., Collins, A. C., Souza, G., Rae, C. S., Schneider, D. S., Nakamura, K., Shiloh, M. U., & Cox, J. S. (2013) · Nature · doi:10.1038/nature12566 · Cited by 588 · see citing works
Phagosomal Rupture by Mycobacterium tuberculosis Results in Toxicity and Host Cell Death
Simeone, R., Bobard, A., Lippmann, J., Bitter, W., Majlessi, L., Brosch, R., & Enninga, J. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002507 · Cited by 561 · see citing works
Self-citationVia, L. E., Deretic, D., Ulmer, R. J., Hibler, N. S., Huber, L. A., & Deretic, V. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.13326 · Cited by 558 · see citing works
Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis
Vergne, I., Chua, J., Lee, H.-H., Lucas, M., Belisle, J. T., & Deretic, V. P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409716102 · Cited by 537 · see citing works
Fratti, R. A., Backer, J., Gruenberg, J. E., Corvera, S., & Deretic, V. P. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200106049 · Cited by 535 · see citing works
Kang, P. B., Azad, A. K., Torrelles, J. B., Kaufman, T. M., Beharka, A. A., Tibesar, E., DesJardin, L. E., & Schlesinger, L. S. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051239 · Cited by 519 · see citing works
Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest
Fratti, R. A., Chua, J., Vergne, I., & Deretic, V. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737613100 · Cited by 509 · see citing works
Manzanillo, P. S., Shiloh, M. U., Portnoy, D. A., & Cox, J. S. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.03.007 · Cited by 456 · see citing works
Manipulation of Host Cell Death Pathways during Microbial Infections
Lamkanfi, M., & Dixit, V. M. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.06.007 · Cited by 450 · see citing works
Mycobacterial survival strategies in the phagosome: defence against host stresses
Ehrt, S., & Schnappinger, D. (2009) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01335.x · Cited by 448 · see citing works
Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis
Behar, S. M., Martin, C. J., Booty, M. G., Nishimura, T., Zhao, X., Gan, H.-X., Divangahi, M., & Remold, H. G. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.3 · Cited by 447 · see citing works
Host Evasion and Exploitation Schemes of Mycobacterium tuberculosis
Cambier, C. J., Falkow, S., & Ramakrishnan, L. (2014) · Cell · doi:10.1016/j.cell.2014.11.024 · Cited by 432 · see citing works
Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy?
Behar, S. M., Divangahi, M., & Remold, H. G. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2387 · Cited by 427 · see citing works
Nigou, J., Zelle‐Rieser, C., Gilleron, M., Thurnher, M., & Puzo, G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7477 · Cited by 423 · see citing works
New insights into the function of granulomas in human tuberculosis
Ulrichs, T., & Kaufmann, S. H. E. (2006) · Journal of Pathology · doi:10.1002/path.1906 · Cited by 421 · see citing works
Wong, D., Bach, H., Sun, J., Hmama, Z., & Av‐Gay, Y. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109201108 · Cited by 417 · see citing works
ESX‐1‐mediated translocation to the cytosol controls virulence of mycobacteria
Houben, D., Demangel, C., van Ingen, J., Pérez, J., Baldeón, L., Abdallah, A. M., Caleechurn, L., Bottai, D., van Zon, M., de Punder, K., et al. (2012) · Cellular Microbiology · doi:10.1111/j.1462-5822.2012.01799.x · Cited by 415 · see citing works
Self-citationWassermann, R., Gulen, M. F., Sala, C., Perin, S. G., Lou, Y., Rybniker, J., Schmid-Burgk, J. L., Schmidt, T., Hornung, V., Cole, S. T., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.05.003 · Cited by 401 · see citing works
Cyclic GMP-AMP Synthase Is an Innate Immune DNA Sensor for Mycobacterium tuberculosis
Collins, A. C., Cai, H., Li, T., Franco, L. H., Li, X.-D., Nair, V. R., Scharn, C. R., Stamm, C. E., Levine, B., Chen, Z. J., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.05.005 · Cited by 384 · see citing works
ESX secretion systems: mycobacterial evolution to counter host immunity
Gröschel, M. I., Sayes, F., Simeone, R., Majlessi, L., & Brosch, R. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.131 · Cited by 382 · see citing works
Self-citationPathogenesis of tuberculosis: interaction of Mycobacterium tuberculosis with macrophages
McDonough, K. A., Kress, Y., & Bloom, B. R. (1993) · Infection and Immunity · doi:10.1128/iai.61.7.2763-2773.1993 · Cited by 377 · see citing works
Mechanisms of pathogen entry through the endosomal compartments
Gruenberg, J., & van der Goot, F. G. (2006) · Nature reviews. Molecular cell biology · doi:10.1038/nrm1959 · Cited by 360 · see citing works
Xu, S., Cooper, A. M., Sturgill-Koszycki, S., van Heyningen, T., Chatterjee, D., Orme, I. M., Allen, P. M., & Russell, D. G. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.6.2568 · Cited by 359 · see citing works
Illuminating the landscape of host–pathogen interactions with the bacterium Listeria monocytogenes
Cossart, P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112371108 · Cited by 351 · see citing works
Mycobacterium tuberculosis nuoG Is a Virulence Gene That Inhibits Apoptosis of Infected Host Cells
Velmurugan, K., Chen, B., Miller, J. L., Azogue, S., Gurses, S. A., Hsu, T., Glickman, M. S., Jacobs, W. R., Porcelli, S. A., & Briken, V. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030110 · Cited by 330 · see citing works
Christophe, T., Jackson, M., Jeon, H. K., Fenistein, D., Contreras-Domínguez, M., Kim, J. C., Genovesio, A., Carralot, J., Ewann, F., Kim, E. H., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000645 · Cited by 325 · see citing works
Self-citationBowdish, D. M. E., Sakamoto, K., Kim, M., Klaas, M., Mukhopadhyay, S., Leifer, C. A., Tryggvason, K., Gordon, S., & Russell, D. G. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000474 · Cited by 320 · see citing works
Survival of Mycobacteria in Macrophages Is Mediated by Coronin 1-Dependent Activation of Calcineurin
Jayachandran, R., Sundaramurthy, V., Combaluzier, B., Mueller, P., Korf, H., Huygen, K., Miyazaki, T., Albrecht, I., Massner, J., & Pieters, J. (2007) · Cell · doi:10.1016/j.cell.2007.04.043 · Cited by 310 · see citing works
Parihar, S. P., Guler, R., Khutlang, R., Lang, D. M., Hurdayal, R., Mhlanga, M., Suzuki, H., Marais, A. D., & Brombacher, F. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jit550 · Cited by 295 · see citing works
Advancing host-directed therapy for tuberculosis
Wallis, R. S., & Hafner, R. (2015) · Nature Reviews Immunology · doi:10.1038/nri3813 · Cited by 291 · see citing works
The balance between protective and pathogenic immune responses in the TB-infected lung
Orme, I. M., Robinson, R., & Cooper, A. M. (2014) · Nature Immunology · doi:10.1038/ni.3048 · Cited by 286 · see citing works
Toll-like receptor pathways in the immune responses to mycobacteria
Quesniaux, V. F. J., Fremond, C., Jacobs, M., Parida, S. K., Nicolle, D. M., Yeremeev, V., Bihl, F., Erard, F., Botha, T., Drennan, M., et al. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.04.016 · Cited by 280 · see citing works
Dectin-2 Is a Direct Receptor for Mannose-Capped Lipoarabinomannan of Mycobacteria
Yonekawa, A., Saijo, S., Hoshino, Y., Miyake, Y., Ishikawa, E., Suzukawa, M., Inoue, H., Tanaka, M., Yoneyama, M., Oh‐hora, M., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.08.005 · Cited by 275 · see citing works
ESX-1 dependent impairment of autophagic flux by Mycobacterium tuberculosis in human dendritic cells
Romagnoli, A., Etna, M. P., Giacomini, E., Pardini, M., Remoli, M. E., Corazzari, M., Falasca, L., Goletti, D., Gafa, V., Siméone, R., et al. (2012) · Autophagy · doi:10.4161/auto.20881 · Cited by 271 · see citing works
Self-citationVanderVen, B. C., Fahey, R. J., Lee, W., Liu, Y., Abramovitch, R. B., Memmott, C., Crowe, A. M., Eltis, L. D., Perola, E., Deininger, D. D., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004679 · Cited by 264 · see citing works
Vergne, I., Fratti, R. A., Hill, P. J., Chua, J., Belisle, J. T., & Deretic, V. P. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-05-0307 · Cited by 260 · see citing works
Toll-Like Receptor Signaling and Its Inducible Proteins
Satoh, T., & Akira, S. (2016) · Microbiology spectrum · doi:10.1128/microbiolspec.mchd-0040-2016 · Cited by 251 · see citing works
Astarie‐Dequeker, C., N’Diaye, E.-N., Cabec, V. L., Rittig, M. G., Prandi, J., & Maridonneau‐Parini, I. (1999) · Infection and Immunity · doi:10.1128/iai.67.2.469-477.1999 · Cited by 250 · see citing works
Conrad, W. H., Osman, M. M., Shanahan, J. K., Chu, F., Takaki, K. K., Cameron, J. R., Hopkinson‐Woolley, D., Brosch, R., & Ramakrishnan, L. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620133114 · Cited by 241 · see citing works
Self-citationAugenstreich, J., Arbues, A., Simeone, R., Haanappel, E., Wegener, A., Sayes, F., Le Chevalier, F., Chalut, C., Malaga, W., Guilhot, C., et al. (2017) · Cellular Microbiology · doi:10.1111/cmi.12726 · Cited by 240 · see citing works
Self-citationQuigley, J., Hughitt, V. K., Velikovsky, C. A., Mariuzza, R. A., El-Sayed, N. M., & Briken, V. (2017) · mBio · doi:10.1128/mbio.00148-17 · Cited by 234 · see citing works
Astarie‐Dequeker, C., Guyader, L. L., Malaga, W., Seaphanh, F.-K., Chalut, C., Lopez, A., & Guilhot, C. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000289 · Cited by 233 · see citing works
Dallenga, T. K., Repnik, U., Corleis, B., Eich, J., Reimer, R., Griffiths, G. W., & Schaible, U. E. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.09.003 · Cited by 231 · see citing works
Bottai, D., Di Luca, M., Majlessi, L., Frigui, W., Simeone, R., Sayes, F., Bitter, W., Brennan, M. J., Leclerc, C., Batoni, G., et al. (2012) · Molecular Microbiology · doi:10.1111/j.1365-2958.2012.08001.x · Cited by 210 · see citing works
Self-citationCritical role for NLRP3 in necrotic death triggered by <i>Mycobacterium tuberculosis</i>
Wong, K., & Jacobs Jr, W. R. (2011) · Cellular Microbiology · doi:10.1111/j.1462-5822.2011.01625.x · Cited by 209 · see citing works
Simeone, R., Sayes, F., Song, O., Gröschel, M. I., Brodin, P., Brosch, R., & Majlessi, L. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004650 · Cited by 198 · see citing works
Self-citationPaulson, T. (2013) · Nature · doi:10.1038/502s2a · Cited by 188 · see citing works
Interaction of Pattern Recognition Receptors with Mycobacterium Tuberculosis
Mortaz, E., Adcock, I. M., Tabarsi, P., Masjedi, M. R., Mansouri, D., Velayati, A. A., Casanova, J., & Barnes, P. J. (2014) · Journal of Clinical Immunology · doi:10.1007/s10875-014-0103-7 · Cited by 174 · see citing works
Phenolic Glycolipid Facilitates Mycobacterial Escape from Microbicidal Tissue-Resident Macrophages
Cambier, C. J., O’Leary, S. M., O’Sullivan, M. P., Keane, J., & Ramakrishnan, L. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.003 · Cited by 158 · see citing works
Direct recruitment of H+-ATPase from lysosomes for phagosomal acidification
Sun‐Wada, G., Tabata, H., Kawamura, N., Aoyama, M., & Wada, Y. (2009) · Journal of Cell Science · doi:10.1242/jcs.050443 · Cited by 153 · see citing works
Mycobacterium tuberculosis replicates within necrotic human macrophages
Lerner, T. R., Borel, S., Greenwood, D. J., Repnik, U., Russell, M. R. G., Herbst, S., Jones, M. L., Collinson, L., Griffiths, G. W., & Gutierrez, M. G. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201603040 · Cited by 151 · see citing works
Delay of phagosome maturation by a mycobacterial lipid is reversed by nitric oxide
Axelrod, S., Oschkinat, H., Enders, J., Schlegel, B., Brinkmann, V., Kaufmann, S. H. E., Haas, A., & Schaible, U. E. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2008.01147.x · Cited by 141 · see citing works
Aguilo, J. I., Alonso, H., Uranga, S., Marinova, D., Arbués, A., de Martino, A., Anel, A., Monzon, M., Badiola, J., Pardo, J., et al. (2013) · Cellular Microbiology · doi:10.1111/cmi.12169 · Cited by 140 · see citing works
Self-citationAguiló, N., Gonzalo‐Asensio, J., Álvarez-Arguedas, S., Marinova, D., Gómez, A. B., Uranga, S., Spallek, R., Singh, M., Audran, R., Spertini, F., et al. (2017) · Nature Communications · doi:10.1038/ncomms16085 · Cited by 128 · see citing works
Towards host-directed therapies for tuberculosis
Zumla, A. I., Chakaya, J. M., Höelscher, M., Ntoumi, F., Rustomjee, R., Vilaplana, C., Yeboah‐Manu, D., Rasolofo, V., Munderi, P., Singh, N., et al. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4696 · Cited by 125 · see citing works
Gröschel, M. I., Sayes, F., Shin, S. J., Frigui, W., Pawlik, A., Orgeur, M., Canetti, R., Honoré, N., Simeone, R., van der Werf, T. S., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.057 · Cited by 125 · see citing works
Self-citationRab GTPases in Immunity and Inflammation
Prashar, A., Schnettger, L., Bernard, E. M., & Gutierrez, M. G. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00435 · Cited by 122 · see citing works
Johnson, B. K., Colvin, C. J., Needle, D. B., Medie, F. M., Champion, P. A. D., & Abramovitch, R. B. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00719-15 · Cited by 121 · see citing works
Mycobacterium tuberculosis Induces an Atypical Cell Death Mode to Escape from Infected Macrophages
Lee, J., Repasy, T., Papavinasasundaram, K. G., Sassetti, C. M., & Kornfeld, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018367 · Cited by 121 · see citing works
Jamwal, S. V., Mehrotra, P., Singh, A. K., Siddiqui, Z., Basu, A., & Rao, K. V. S. (2016) · Scientific Reports · doi:10.1038/srep23089 · Cited by 121 · see citing works
Barczak, A. K., Avraham, R., Singh, S., Luo, S. S., Zhang, W. R., Bray, M.-A., Hinman, A. E., Thompson, M., Nietupski, R. M., Golas, A., et al. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006363 · Cited by 120 · see citing works
Simvastatin increases the in vivo activity of the first-line tuberculosis regimen
Skerry, C. M., Pinn, M. L., Bruiners, N., Pine, R. I., Gennaro, M. L., & Karakousis, P. C. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku166 · Cited by 119 · see citing works
Host-Directed Therapies for Tuberculosis: Figure 1.Preprint
Tobin, D. M. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a021196 · Cited by 119 · see citing works
Functional role(s) of phagosomal Rab GTPases
Gutierrez, M. G. (2013) · Small GTPases · doi:10.4161/sgtp.25604 · Cited by 118 · see citing works
Sayes, F., Sun, L., Luca, M. D., Siméone, R., Degaiffier, N., Fiette, L., Esin, S., Brosch, R., Bottai, D., Leclerc, C., et al. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.03.003 · Cited by 116 · see citing works
Self-citationMyrvik, Q. N., Leake, E. S., & Wright, M. J. (1984) · PubMed · Cited by 114 · see citing works
Autophagy as a basis for the health-promoting effects of vitamin D
Høyer-Hansen, M. H., Nordbrandt, S. P. S., & Jäättelä, M. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.04.005 · Cited by 112 · see citing works
Beckham, K. S. H., Ciccarelli, L., Bunduc, C. M., Mertens, H. D. T., Ummels, R., Lugmayr, W., Mayr, J., Rettel, M., Savitski, M. M., Svergun, D. I., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.47 · Cited by 112 · see citing works
Statins Increase Rifampin Mycobactericidal Effect
Lobato, L. S., Rosa, P. S., Ferreira, J. D. S., Neumann, A. D. S., da Silva, M. G., do Nascimento, D. C., Soares, C. T., Pedrini, S. C. B., de Oliveira, D. S. L., Monteiro, C. P., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01826-13 · Cited by 110 · see citing works
van de Veerdonk, F. L., Teirlinck, A. C., Kleinnijenhuis, J., Kullberg, B. J., van Crevel, R., van der Meer, J. W. M., Joosten, L. A. B., & Netea, M. G. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0809550 · Cited by 108 · see citing works
Villeneuve, C., Gilleron, M., Maridonneau‐Parini, I., Daffé, M., Astarie‐Dequeker, C., & Etienne, G. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400308-jlr200 · Cited by 108 · see citing works
pks5-recombination-mediated surface remodelling in Mycobacterium tuberculosis emergence
Boritsch, E. C., Frigui, W., Cascioferro, A., Malaga, W., Etienne, G., Laval, F., Pawlik, A., Le Chevalier, F., Orgeur, M., Ma, L., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2015.19 · Cited by 104 · see citing works
Self-citationSchnettger, L., Rodgers, A., Repnik, U., Lai, R., Pei, G., Verdoes, M., Wilkinson, R. J., Young, D., & Gutierrez, M. G. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.04.004 · Cited by 102 · see citing works
Wheelwright, M., Kim, E. W., Inkeles, M. S., Leon, A. A. D., Pellegrini, M. A., Krutzik, S. R., & Liu, P. T. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301686 · Cited by 101 · see citing works
Anticytolytic Screen Identifies Inhibitors of Mycobacterial Virulence Protein Secretion
Rybniker, J., Chen, J. M., Sala, C., Hartkoorn, R. C., Vocat, A., Benjak, A., Boy‐Röttger, S., Zhang, M., Székely, R., Greff, Z., et al. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.09.008 · Cited by 98 · see citing works
XDR tuberculosis: an indicator of public-health negligence
Rie, A. V., & Enarson, D. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69575-5 · Cited by 94 · see citing works
Toyonaga, K., Torigoe, S., Motomura, Y., Kamichi, T., Hayashi, J. M., Morita, Y. S., Noguchi, N., Chuma, Y., Kiyohara, H., Matsuo, K., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.10.012 · Cited by 94 · see citing works
Mycobacterium tuberculosis Controls Phagosomal Acidification by Targeting CISH-Mediated Signaling
Queval, C. J., Song, O., Carralot, J., Saliou, J., Bongiovanni, A., Deloison, G., Deboosère, N., Jouny, S., Iantomasi, R., Delorme, V., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.101 · Cited by 94 · see citing works
Self-citationMmpL transporter-mediated export of cell-wall associated lipids and siderophores in mycobacteria
Chalut, C. (2016) · Tuberculosis · doi:10.1016/j.tube.2016.06.004 · Cited by 85 · see citing works
Genetics of Capsular Polysaccharides and Cell Envelope (Glyco)lipids
Daffé, M., Crick, D., & Jackson, M. (2014) · Microbiology spectrum · doi:10.1128/microbiolspec.mgm2-0021-2013 · Cited by 84 · see citing works
Gengenbacher, M., Nieuwenhuizen, N. E., Vogelzang, A., Liu, H., Kaiser, P., Schuerer, S., Lazar, D., Wagner, I., Mollenkopf, H., & Kaufmann, S. H. E. (2016) · mBio · doi:10.1128/mbio.00679-16 · Cited by 84 · see citing works
Passemar, C., Arbués, A., Malaga, W., Mercier, I., Moreau, F., Lepourry, L., Neyrolles, O., Guilhot, C., & Astarie‐Dequeker, C. (2013) · Cellular Microbiology · doi:10.1111/cmi.12214 · Cited by 82 · see citing works
Ubiquilin 1 Promotes IFN-γ-Induced Xenophagy of Mycobacterium tuberculosis
Sakowski, E. T., Köster, S., Portal‐Celhay, C., Park, H. S., Shrestha, E., Hetzenecker, S. E. G., Maurer, K., Cadwell, K., & Philips, J. A. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005076 · Cited by 80 · see citing works
The survival kit of Mycobacterium tuberculosis
Warner, D. F., & Mizrahi, V. (2007) · Nature Medicine · doi:10.1038/nm0307-282 · Cited by 74 · see citing works
Ullrich, H., Beatty, W. L., & Russell, D. G. (1999) · European Journal of Cell Biology · doi:10.1016/s0171-9335(99)80042-9 · Cited by 69 · see citing works
Dinadayala, P., Lemassu, A., Granovski, P., Cérantola, S., Winter, N., & Daffé, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308908200 · Cited by 68 · see citing works
ESAT-6–dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivo
Kupz, A., Zedler, U., Stäber, M., Perdomo, C., Dorhoi, A., Brosch, R., & Kaufmann, S. H. E. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84978 · Cited by 67 · see citing works
Self-citationSize-dependent mechanism of cargo sorting during lysosome-phagosome fusion is controlled by Rab34
Kasmapour, B., Gronow, A., Bleck, C. K. E., Hong, W., & Gutierrez, M. G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206811109 · Cited by 64 · see citing works
Cytokines in the Balance of Protection and Pathology During Mycobacterial Infections
Torrado, E., & Cooper, A. M. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-6111-1_7 · Cited by 62 · see citing works
Bottai, D., Frigui, W., Clark, S., Rayner, E., Zelmer, A., Andreu, N., de Jonge, M. I., Bancroft, G. J., Williams, A., Brodin, P., et al. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.03.083 · Cited by 60 · see citing works
Self-citationSayes, F., Pawlik, A., Frigui, W., Gröschel, M. I., Samuel, C., Fayolle, C., Cia, F., Bancroft, G. J., Bottai, D., Leclerc, C., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005770 · Cited by 58 · see citing works
Self-citationMTBVAC from discovery to clinical trials in tuberculosis-endemic countries
Marinova, D., Gonzalo‐Asensio, J., Aguiló, N., & Martı́n, C. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1324303 · Cited by 54 · see citing works
Revisiting the role of phospholipases C in virulence and the lifecycle of Mycobacterium tuberculosis
Chevalier, F. L., Cascioferro, A., Frigui, W., Pawlik, A., Boritsch, E. C., Bottai, D., Majlessi, L., Herrmann, J., & Brosch, R. (2015) · Scientific Reports · doi:10.1038/srep16918 · Cited by 49 · see citing works
Self-citationMishra, A., Akhtar, S., Jagannath, C., & Khan, A. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.05.001 · Cited by 49 · see citing works
Leake, E. S., Myrvik, Q. N., & Wright, M. J. (1984) · Infection and Immunity · doi:10.1128/iai.45.2.443-446.1984 · Cited by 48 · see citing works
How is the phagocyte lectin keyboard played? Master class lesson by Mycobacterium tuberculosis
Tailleux, L., Maeda, N., Nigou, J., Gicquel, B., & Neyrolles, O. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(03)00102-1 · Cited by 47 · see citing works
Patin, E. C., Geffken, A. C., Willcocks, S., Leschczyk, C., Haas, A., Nimmerjahn, F., Lang, R., Ward, T. H., & Schaible, U. E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174973 · Cited by 47 · see citing works
Mycobacterium tuberculosis Meets the Cytosol: The Role of cGAS in Anti-mycobacterial Immunity
Majlessi, L., & Brosch, R. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.05.017 · Cited by 45 · see citing works
Self-citationPolymorphic Allele of Human MRC1 Confer Protection against Tuberculosis in a Chinese Population
Zhang, X., Jiang, F., Wei, L., Li, F., Liu, J., Wang, C., Zhao, M., Jiang, T., Xu, D., Fan, D., et al. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4047 · Cited by 32 · see citing works
C-type lectins with a sweet spot forMycobacterium tuberculosis
Lugo‐Villarino, G., Hudrisier, D., Tanne, A. J., & Neyrolles, O. (2011) · European Journal of Microbiology and Immunology · doi:10.1556/eujmi.1.2011.1.6 · Cited by 31 · see citing works
Towards anti-virulence drugs targeting ESX-1 mediated pathogenesis of Mycobacterium tuberculosis
Chen, J. M., Pojer, F., Blasco, B., & Cole, S. T. (2010) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2010.09.002 · Cited by 30 · see citing works
Vázquez, C. L., Rodgers, A., Herbst, S., Coade, S. B., Gronow, A., Guzmán, C. A., Wilson, M. S., Kanzaki, M., Nykjær, A., & Gutierrez, M. G. (2016) · Scientific Reports · doi:10.1038/srep29332 · Cited by 30 · see citing works
The ins and outs of theMycobacterium tuberculosis-containing vacuole
Russell, D. G. (2016) · Cellular Microbiology · doi:10.1111/cmi.12623 · Cited by 27 · see citing works
Perspectives on mycobacterial vacuole-to-cytosol translocation: the importance of cytosolic access
Siméone, R., Majlessi, L., Enninga, J., & Brosch, R. (2016) · Cellular Microbiology · doi:10.1111/cmi.12622 · Cited by 26 · see citing works
Self-citationTargeting Type VII/ESX Secretion Systems for Development of Novel Antimycobacterial Drugs
Bottai, D., Serafini, A., Cascioferro, A., Brosch, R., & Manganelli, R. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612819666131118170717 · Cited by 21 · see citing works
Self-citationStriking the Right Balance Determines TB or Not TB
Dasgupta, S. B., & Pieters, J. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00455 · Cited by 20 · see citing works
Tanne, A. J., & Neyrolles, O. (2010) · Virulence · doi:10.4161/viru.1.4.11967 · Cited by 19 · see citing works
Flagged first, then by citations
1 of the 132 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Functions of ROS in Macrophages and Antimicrobial Immunity
Herb, M., & Schramm, M. (2021) · Antioxidants · doi:10.3390/antiox10020313 · Cited by 633 · see citing works
Immune Response to Mycobacterium tuberculosis: A Narrative Review
de Martino, M., Lodi, L., Galli, L., & Chiappini, E. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00350 · Cited by 356 · see citing works
PE/PPE proteins mediate nutrient transport across the outer membrane of Mycobacterium tuberculosis
Wang, Q., Boshoff, H. I., Harrison, J. R., Ray, P. C., Green, S. R., Wyatt, P. G., & Barry, C. E. (2020) · Science · doi:10.1126/science.aav5912 · Cited by 189 · see citing works
Macrophage: A Cell With Many Faces and Functions in Tuberculosis
Ahmad, F., Rani, A., Alam, A., Zarin, S., Pandey, S., Singh, H., Hasnain, S. E., & Ehtesham, N. Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.747799 · Cited by 200 · see citing works
Kanabalan, R. D., Lee, L. J., Lee, T. Y., Chong, P. P., Hassan, L., Ismail, R., & Chin, V. K. (2021) · Microbiological Research · doi:10.1016/j.micres.2020.126674 · Cited by 177 · see citing works
Tuberculosis Drug Discovery: Challenges and New Horizons
Fernandes, G., Thompson, A. M., Castagnolo, D., Denny, W. A., & dos Santos, J. L. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00227 · Cited by 152 · see citing works
Zulauf, K. E., Sullivan, J. T., & Braunstein, M. (2018) · PLOS Pathogens · doi:10.1371/journal.ppat.1007011 · Cited by 120 · see citing works
An update on derivatisation and repurposing of clinical nitrofuran drugs
Zuma, N. H., Aucamp, J., & N’Da, D. D. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.105092 · Cited by 104 · see citing works
Lc3-associated phagocytosis—The highway to hell for phagocytosed microbes
Herb, M., Gluschko, A., & Schramm, M. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.04.016 · Cited by 103 · see citing works
Autophagy restricts Mycobacterium tuberculosis during acute infection in mice
Golovkine, G. R., Roberts, A. W., Morrison, H. M., Rivera‐Lugo, R., McCall, R. M., Nilsson, H., Garelis, N. E., Repasy, T., Cronce, M. J., Budzik, J. M., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01354-6 · Cited by 102 · see citing works
Immunometabolism of Phagocytes During Mycobacterium tuberculosis Infection
Kumar, R., Singh, P., Kolloli, A., Shi, L., Bushkin, Y., Tyagi, S., & Subbian, S. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00105 · Cited by 99 · see citing works
Carow, B., Hauling, T., Qian, X., Kramnik, I., Nilsson, M. F., & Rottenberg, M. E. (2019) · Nature Communications · doi:10.1038/s41467-019-09816-4 · Cited by 101 · see citing works
Maphasa, R. E., Meyer, M., & Dube, A. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.618414 · Cited by 100 · see citing works
Clinical manifestations and immune response to tuberculosis
Carabalí-Isajar, M. L., Rodríguez-Bejarano, O. H., Amado, T., Patarroyo, M. A., Izquierdo, M. A., Lutz, J. R., & Ocampo, M. (2023) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-023-03636-x · Cited by 101 · see citing works
Mitochondrial metabolism mediated macrophage polarization in chronic lung diseases
Dong, T., Chen, X., Xu, H., Song, Y., Wang, H., Gao, Y., Wang, J., Du, R., Lou, H., & Dong, T. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108208 · Cited by 101 · see citing works
Silver Nanoparticles for the Therapy of Tuberculosis
Tăbăran, F., MATEA, C. T., Mocan, T., Tăbăran, F., Mihaiu, M., Iancu, C., & MOCAN, L. C. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s241183 · Cited by 92 · see citing works
Kim, B.-R., Kim, B.-J., Kook, Y., & Kim, B. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008294 · Cited by 89 · see citing works
Host Cell Targets of Released Lipid and Secreted Protein Effectors of Mycobacterium tuberculosis
Augenstreich, J., & Briken, V. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.595029 · Cited by 76 · see citing works
Machelart, A., Salzano, G., Li, X., Demars, A. M., Debrie, A., Menéndez-Miranda, M., Pancani, E., Jouny, S., Hoffmann, E., Deboosère, N., et al. (2019) · ACS Nano · doi:10.1021/acsnano.8b07902 · Cited by 69 · see citing works
Self-citationFoster, M., Hill, P. C., Setiabudiawan, T. P., Koeken, V. A. C. M., Alisjahbana, B., & van Crevel, R. (2021) · Immunological Reviews · doi:10.1111/imr.12965 · Cited by 71 · see citing works
Host-Directed Therapies for Tuberculosis
Jeong, E.-K., Lee, H.-J., & Jung, Y. (2022) · Pathogens · doi:10.3390/pathogens11111291 · Cited by 74 · see citing works
Adaptations of intracellular bacteria to vacuolar or cytosolic niches
Petit, T. J. P., & Lebreton, A. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2022.01.015 · Cited by 63 · see citing works
Dubois, V., Viljoen, A. J., Laencina, L., Moigne, V. L., Bernut, A., Dubar, F., Blaise, M., Herrmann, J., Guérardel, Y., Kremer, L., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812984115 · Cited by 62 · see citing works
The Interplay of Host Lysosomes and Intracellular Pathogens
Sachdeva, K. S., & Sundaramurthy, V. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.595502 · Cited by 61 · see citing works
Targeting immunometabolism in host defence against Mycobacterium tuberculosis
Sheedy, F. J., & Divangahi, M. (2020) · Immunology · doi:10.1111/imm.13276 · Cited by 59 · see citing works
Yuki, K. E., Marei, H., Fiškin, E., Eva, M. M., Gopal, A. A., Schwartzentruber, J., Majewski, J., Cellier, M. F., Mandl, J. N., Vidal, S. M., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0484-8 · Cited by 56 · see citing works
Roles for phthiocerol dimycocerosate lipids in Mycobacterium tuberculosis pathogenesis
Rens, C., Chao, J. D., Sexton, D. L., Tocheva, E. I., & Av‐Gay, Y. (2021) · Microbiology · doi:10.1099/mic.0.001042 · Cited by 56 · see citing works
Dwivedy, A., Ashraf, A., Jha, B., Kumar, D., Agarwal, N., & Biswal, B. K. (2021) · Communications Biology · doi:10.1038/s42003-021-01926-4 · Cited by 53 · see citing works
Smulan, L. J., Martinez, N., Kiritsy, M. C., Kativhu, C. L., Cavallo, K., Sassetti, C. M., Singhal, A., Remold, H. G., & Kornfeld, H. (2021) · mBio · doi:10.1128/mbio.03140-20 · Cited by 52 · see citing works
Bouzeyen, R., Haoues, M., Barbouche, M., Singh, R., & Essafi, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02922 · Cited by 52 · see citing works
ESX/Type VII Secretion Systems—An Important Way Out for Mycobacterial Proteins
Vaziri, F., & Brosch, R. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.psib-0029-2019 · Cited by 50 · see citing works
Self-citationPolyphosphate is an extracellular signal that can facilitate bacterial survival in eukaryotic cells
Rijal, R., Cadena, L. A., Smith, M., Carr, J. F., & Gomer, R. H. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2012009117 · Cited by 44 · see citing works
Larsen, S. E., Williams, B. D., Rais, M., Coler, R. N., & Baldwin, S. L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.840225 · Cited by 50 · see citing works
In vitro drug discovery models for Mycobacterium tuberculosis relevant for host infection
Parish, T. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1707801 · Cited by 47 · see citing works
Mechanisms of lung damage in tuberculosis: implications for chronic obstructive pulmonary disease
Kayongo, A., Nyiro, B., Siddharthan, T., Kirenga, B., Checkley, W., Joloba, M. L., Ellner, J. J., & Salgame, P. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1146571 · Cited by 51 · see citing works
Niekamp, P., Guzman, G., Leier, H. C., Rashidfarrokhi, A., Richina, V., Pott, F., Barisch, C., Holthuis, J. C. M., & Tafesse, F. (2021) · mBio · doi:10.1128/mbio.03141-20 · Cited by 45 · see citing works
Mouse Models for Mycobacterium tuberculosis Pathogenesis: Show and Do Not Tell
Soldevilla, P., Vilaplana, C., & Cardona, P.-J. (2022) · Pathogens · doi:10.3390/pathogens12010049 · Cited by 46 · see citing works
Baral, B., & Mozafari, M. R. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00005 · Cited by 42 · see citing works
Vieira, A. C. C., Chaves, L. L., Pinheiro, M., Lima, S. A. C., Neto, P. J. R., Ferreira, D., Sarmento, B. F. C. C., & Reis, S. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.116978 · Cited by 42 · see citing works
Gastrointestinal tissue as a “new” target of pollution exposure
Pambianchi, E., Pecorelli, A., & Valacchi, G. (2021) · IUBMB Life · doi:10.1002/iub.2530 · Cited by 42 · see citing works
High-resolution longitudinal N- and O-glycoprofiling of human monocyte-to-macrophage transition
Hinneburg, H., Pedersen, J. L., Bokil, N. J., Pralow, A., Schirmeister, F., Kawahara, R., Rapp, E., Saunders, B. M., & Thaysen‐Andersen, M. (2020) · Glycobiology · doi:10.1093/glycob/cwaa020 · Cited by 41 · see citing works
Nanosized Drug Delivery Systems to Fight Tuberculosis
Bourguignon, T., Godinez-Leon, J. A., & Gref, R. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020393 · Cited by 40 · see citing works
Raykov, L., Mottet, M., Nitschke, J., & Soldati, T. (2023) · eLife · doi:10.7554/elife.85727 · Cited by 35 · see citing works
Kidwai, S., Bouzeyen, R., Chakraborti, S., Khare, N., Das, S., Gosain, T. P., Behura, A., Meena, C. L., Dhiman, R., Essafi, M., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00996-19 · Cited by 40 · see citing works
Macrophages use a bet-hedging strategy for antimicrobial activity in phagolysosomal acidification
Dragotakes, Q., Stouffer, K. M., Fu, M. S., Sella, Y., Youn, C., Yoon, O. I., Leon-Rodriguez, C. M. D., Freij, J. B., Bergman, A., & Casadevall, A. (2020) · Journal of Clinical Investigation · doi:10.1172/jci133938 · Cited by 40 · see citing works
Marando, V. M., Kim, D. E., Calabretta, P. J., Kraft, M. B., Bryson, B. D., & Kiessling, L. L. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c07430 · Cited by 39 · see citing works
Lafuente, B. I., Ummels, R., Kuijl, C. P., Bitter, W., & Speer, A. (2021) · mBio · doi:10.1128/mbio.02983-20 · Cited by 39 · see citing works
Breaching the phagosome, the case of the tuberculosis agent
Siméone, R., Sayes, F., Lawarée, E., & Brosch, R. (2021) · Cellular Microbiology · doi:10.1111/cmi.13344 · Cited by 36 · see citing works
Self-citationTak, U., Vlach, J., Garza-Garcı́a, A., William, D., Danilchanka, O., de Carvalho, L. P. S., Saad, J. S., & Niederweis, M. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005832 · Cited by 38 · see citing works
Jiang, F., Lou, J., Zheng, X., & Yang, X.-Y. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.07.023 · Cited by 37 · see citing works
Ehtram, A., Shariq, M., Ali, S., Quadir, N., Sheikh, J. A., Faraz, A., Sharma, T., Ehtesham, N. Z., & Hasnain, S. E. (2021) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2021.151495 · Cited by 36 · see citing works
Mannose-Decorated Solid-Lipid Nanoparticles for Alveolar Macrophage Targeted Delivery of Rifampicin
Bera, H., Zhao, C., Tian, X., Cun, D., & Yang, M. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16030429 · Cited by 35 · see citing works
Hall, T. J., Vernimmen, D., Browne, J. A., Mullen, M. P., Gordon, S. V., MacHugh, D. E., & O’Doherty, A. M. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2019.01386 · Cited by 38 · see citing works
Cadmus, S., Akinseye, V. O., Taiwo, B., Pinelli, E., van Soolingen, D., & Rhodes, S. G. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008069 · Cited by 34 · see citing works
Graphene Oxide-Linezolid Combination as Potential New Anti-Tuberculosis Treatment
Maio, F. D., Palmieri, V., Santarelli, G., Perini, G., Salustri, A., Palucci, I., Sali, M., Gervasoni, J., Primiano, A., Ciasca, G., et al. (2020) · Nanomaterials · doi:10.3390/nano10081431 · Cited by 34 · see citing works
Park, H.-E., Park, H.-T., Jung, Y. H., & Yoo, H. S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196502 · Cited by 32 · see citing works
Parbhoo, T., Mouton, J., & Sampson, S. L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.956607 · Cited by 36 · see citing works
Afriyie-Asante, A., Dabla, A., Dagenais, A., Berton, S., Smyth, R., & Sun, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.742370 · Cited by 32 · see citing works
Hunter, L., Hingley‐Wilson, S., Stewart, G. R., Sharpe, S. A., & Salguero, F. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.776913 · Cited by 31 · see citing works
Emerging patterns of regulatory T cell function in tuberculosis
Ahmed, A., & Vyakarnam, A. (2020) · Clinical & Experimental Immunology · doi:10.1111/cei.13488 · Cited by 30 · see citing works
An Interplay Between Autophagy and Immunometabolism for Host Defense Against Mycobacterial Infection
Paik, S., & Jo, E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.603951 · Cited by 30 · see citing works
Wang, D., Lin, Y., Xu, F., Zhang, H., Zhu, X., Liu, Z., Hu, Y., Dong, G., Sun, B., Yu, Y., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104278 · Cited by 32 · see citing works
Crawford, M. S., Nordgren, T. M., & McCole, D. F. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00423.2020 · Cited by 30 · see citing works
E-cigarettes: Effects in phagocytosis and cytokines response against Mycobacterium tuberculosis
Gómez, A.-C., Rodríguez-Fernández, P., Villar-Hernández, R., Gibert, I., Muriel-Moreno, B., Lacoma, A., Prat, C., & Domínguez, J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228919 · Cited by 29 · see citing works
Rankine-Wilson, L., Shapira, T., Emani, C. S., & Av‐Gay, Y. (2021) · Microbiology · doi:10.1099/mic.0.001041 · Cited by 28 · see citing works
Application of liposomes in the treatment of infectious diseases
Suhaimi, N. A. A., Ahmad, S., Husna, S. M. N., Sarmiento, M. E., Acosta, A., Norazmi, M. N., Ibrahim, J., Mohamud, R., & Kadir, R. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120734 · Cited by 28 · see citing works
Treatments of Mycobacterium tuberculosis and Toxoplasma gondii with Selenium Nanoparticles
Ifijen, I. H., Atoe, B., Ekun, R. O., Ighodaro, A., & Odiachi, I. J. (2023) · BioNanoScience · doi:10.1007/s12668-023-01059-4 · Cited by 28 · see citing works
Singh, S., Maurya, S. K., Aqdas, M., Bashir, H., Arora, A., Bhalla, V., & Agrewala, J. N. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04596-5 · Cited by 27 · see citing works
Integrative genomics of the mammalian alveolar macrophage response to intracellular mycobacteria
Hall, T. J., Mullen, M. P., McHugo, G. P., Killick, K. E., Ring, S. C., Berry, D. P., Correia, C. N., Browne, J. A., Gordon, S. V., & MacHugh, D. E. (2021) · BMC Genomics · doi:10.1186/s12864-021-07643-w · Cited by 30 · see citing works
Liu, S., Xie, Y., Luo, W., Dou, Y., Xiong, H., Xiao, Z., & Zhang, X. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00845 · Cited by 26 · see citing works
Queval, C. J., Fearns, A., Botella, L., Smyth, A., Schnettger, L., Mitermite, M., Wooff, E. E., Villarreal‐Ramos, B., García‐Jiménez, W., Heunis, T. D. J., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009410 · Cited by 26 · see citing works
Self-citationMekonnen, D. S., Derbie, A., Mihret, A., Yimer, S. A., Tønjum, T., Gelaw, B., Nibret, E., Munshae, A., Waddell, S. J., & Aseffa, A. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01550-5 · Cited by 25 · see citing works
Khoza, L. J., Kumar, P., Dube, A., Demana, P. H., & Choonara, Y. E. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121893 · Cited by 24 · see citing works
Trousil, J., Dal, N. K., Fenaroli, F., Schlachet, I., Kubíčková, P., Janoušková, O., Pavlová, E., Škorič, M., Trejbalová, K., Pavliš, O., et al. (2022) · Small · doi:10.1002/smll.202201853 · Cited by 24 · see citing works
Yuan, Y., Lin, D., Feng, L., Huang, M., Yan, H., Li, Y., Chen, Y., Lin, B., Ma, Y., Ye, Z., et al. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1654-9 · Cited by 23 · see citing works
Dadhich, R., & Kapoor, S. (2020) · The Journal of Membrane Biology · doi:10.1007/s00232-020-00135-0 · Cited by 23 · see citing works
Rémot, A., Carreras, F., Coupé, A., Doz, E., Boschiroli, M. L., Browne, J. A., Marquant, Q., Descamps, D., Archer, F., Aseffa, A., et al. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.696525 · Cited by 21 · see citing works
Distel, J. S., Venanzio, G. D., Mackel, J. J., Rosen, D. A., & Feldman, M. F. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011173 · Cited by 23 · see citing works
Dissecting Host-Pathogen Interactions in TB Using Systems-Based Omic Approaches
Borah, K., Xu, Y., & McFadden, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.762315 · Cited by 22 · see citing works
Choudhary, E., Bullen, C. K., Goel, R., Singh, A. K., Praharaj, M., Thakur, P., Dhiman, R., Bishai, W. R., & Agarwal, N. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00895 · Cited by 21 · see citing works
Recent Advances in Host-Directed Therapies for Tuberculosis and Malaria
Matteucci, K. C., Correa, A. A. D. S., & Costa, D. L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.905278 · Cited by 21 · see citing works
Human pluripotent stem cell-derived macrophages host Mycobacterium abscessus infection
Sun, S., See, M., Nim, H. T., Strumila, K. A., Ng, E. S., Hidalgo, A., Ramialison, M., SUTTON, P. R. N., Elefanty, A. G., Sarkar, S., et al. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.07.013 · Cited by 21 · see citing works
Extracellular matrix-inspired inhalable aerogels for rapid clearance of pulmonary tuberculosis
Simonson, A. W., Umstead, T. M., Lawanprasert, A., Klein, B., Almarzooqi, S., Halstead, E. S., & Medina, S. H. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120848 · Cited by 21 · see citing works
Post tuberculosis lung disease and tuberculosis sequelae: A narrative review
Cupido, G. C., & Günther, G. (2023) · Indian Journal of Tuberculosis · doi:10.1016/j.ijtb.2023.04.001 · Cited by 20 · see citing works
von Rosen, T., Keller, L. M. L., & Weber-Ban, E. U. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.685757 · Cited by 19 · see citing works
Behura, A., Das, M., Kumar, A., Naik, L., Mishra, A., Manna, D., Patel, S., Mishra, A., Singh, R., & Dhiman, R. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108319 · Cited by 20 · see citing works
Tweaking host immune responses for novel therapeutic approaches against Mycobacterium tuberculosis
Roy, A., Agnivesh, P. K., Sau, S., Kumar, S., & Kalia, N. P. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103693 · Cited by 20 · see citing works
Virulence-Associated Secretion in Mycobacterium abscessus
Bar-Oz, M., Meir, M., & Barkan, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.938895 · Cited by 19 · see citing works
Meikle, V., Mossberg, A., Mitra, A., Håkansson, A., & Niederweis, M. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01846-18 · Cited by 18 · see citing works
Js, K., Kim, Y.-R., & Yang, C. (2019) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1908.08057 · Cited by 17 · see citing works
Magoulopoulou, A., Qian, X., Setiabudiawan, T. P., Salas, S. M., Yokota, C., Rottenberg, M. E., Nilsson, M. F., & Carow, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.876321 · Cited by 15 · see citing works
Host-directed therapy against tuberculosis: Concept and recent developments
Udinia, S., Suar, M., & Kumar, D. (2023) · Journal of Biosciences · doi:10.1007/s12038-023-00374-y · Cited by 15 · see citing works
LPS restores protective immunity in macrophages against Mycobacterium tuberculosis via autophagy
Fang, F., Ge, Q., Li, R. Q., Lv, J., Zhang, Y., Feng, A., Kelly, G. T., Wang, H., Wang, X., Song, C., et al. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.05.001 · Cited by 16 · see citing works
CD44 receptor targeted nanoparticles augment immunity against tuberculosis in mice
Singh, V. K., Chau, E. P., Mishra, A., DeAnda, A., Hegde, V. L., Sastry, K. J., Haviland, D., Jagannath, C., Godin, B., & Khan, A. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.07.040 · Cited by 16 · see citing works
Zhou, X., Yang, J., Zhang, Z., Zhang, L., Lie, L., Zhu, B., Xu, L., Gao, Y., Du, X., Huang, Y., et al. (2019) · Journal of Infection · doi:10.1016/j.jinf.2019.06.007 · Cited by 14 · see citing works
Ufimtseva, E., Eremeeva, N., Bayborodin, S. I., Umpeleva, T. V., Vakhrusheva, D. V., & Skornyakov, S. (2018) · Tuberculosis · doi:10.1016/j.tube.2018.12.002 · Cited by 15 · see citing works
Anil, A., Apte, S., Joseph, J., Parthasarathy, A., Madhavan, S., & Banerjee, A. (2021) · Journal of Bacteriology · doi:10.1128/jb.00439-21 · Cited by 15 · see citing works
Ahmad, Z., Mir, M. A., Sheikh, B. A., & Bhat, B. A. (2021) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023666211222164938 · Cited by 15 · see citing works
Gunawan, C. K., Sumarpo, A., & Indrati, A. R. (2026) · Pathogens · doi:10.3390/pathogens15010051 · Cited by 14 · see citing works
Multi-Functional MPT Protein as a Therapeutic Agent against Mycobacterium tuberculosis
Kim, J., Cho, E., Mun, S., Kim, S., Kim, S., Kim, D.-G., Son, W., Jeon, H.-I., Kim, H.-K., Jeong, Y.-J., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9050545 · Cited by 14 · see citing works
- Authors
- Queval, C. J., Brosch, R., & Simeone, R.
- Affiliations
- Institut Pasteur (FR)
- ORCID
- Brosch, Roland
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2017-11-23
- Volume
- 8
- Pages
- 2284-2284
- ISSN
- 1664-302X (ISSN-L)
- PMC
- PMC5703847
- OpenAlex
- W2769733874
- Cited by
- 215
- References
- 132
- Citations by year
- 2026: 13 · 2025: 18 · 2024: 12 · 2023: 22 · 2022: 43 · 2021: 44 · 2020: 34 · 2019: 18 · 2018: 11
- FWCI
- 2.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Frontiers in Microbiology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- European Commission (ANR-10-LABX-62-IBEID, TBVAC2020, 643381)
- Agence Nationale de la Recherche (10-LABX-62-IBEID, ANR‐10‐LABX‐62‐IBEID, ANR-16-CE15-0003, LABX-62-IBEID, ANR-14-JAMR-001-02, ANR-16, ANR-10, ANR-10-LABX, ANR-10-LABX-0062, TBVAC2020, ANR-14-JAMR-0001, ANR-10-LABX-62)
- Fondation pour la Recherche Médicale (ANR-10-LABX-62-IBEID, DEQ20130326471)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Keywords
- Mycobacterium tuberculosis, tuberculosis, alveolar macrophages, phagosome, phagolysosome biogenesis, phagosome acidification, bacterial dissemination, host-pathogen interaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review